» Articles » PMID: 15563019

Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex

Overview
Journal J Child Neurol
Specialties Neurology
Pediatrics
Date 2004 Nov 26
PMID 15563019
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberous sclerosis complex results from mutations in the TSC1 (hamartin) and TSC2 (tuberin) genes. Tubers are cortical developmental malformations in patients with tuberous sclerosis complex that are associated with intractable epilepsy and are composed of histologically distinct cell types, including giant cells and dysplastic neurons. We recently showed that tubers can be dynamic lesions characterized by populations of cells undergoing proliferation, migration, and death. We demonstrate that there is cell-specific activation of the mammalian target of rapamycin (mTOR)/p70S6 kinase/ribosomal S6 cascade in tubers and that giant cells express activated (phosphorylated) p70S6 kinase and ribosomal S6 protein. These findings support impaired hamartin- and tuberin-mediated mTOR pathway regulation. Tubers likely form by constitutive activation of the mTOR cascade during brain development as a consequence of impaired hamartin or tuberin function.

Citing Articles

Specific Features of Focal Cortical Dysplasia in Tuberous Sclerosis Complex.

Bychkova E, Dorofeeva M, Levov A, Kislyakov A, Karandasheva K, Strelnikov V Curr Issues Mol Biol. 2023; 45(5):3977-3996.

PMID: 37232723 PMC: 10217757. DOI: 10.3390/cimb45050254.


Treatment of Pediatric Low-Grade Gliomas.

Farouk Sait S, Giantini-Larsen A, Tringale K, Souweidane M, Karajannis M Curr Neurol Neurosci Rep. 2023; 23(4):185-199.

PMID: 36881254 PMC: 10121885. DOI: 10.1007/s11910-023-01257-3.


Qualitative and quantitative evaluation for the heterogeneity of cortical tubers using structural imaging and diffusion-weighted imaging to predict the epileptogenicity in tuberous sclerosis complex patients.

Yogi A, Hirata Y, Linetsky M, Ellingson B, Salamon N Neuroradiology. 2022; 65(4):845-853.

PMID: 36456893 DOI: 10.1007/s00234-022-03094-6.


Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex.

Ihnen S, Capal J, Horn P, Griffith M, Sahin M, Bebin E Pediatr Neurol. 2021; 123:1-9.

PMID: 34343869 PMC: 8487620. DOI: 10.1016/j.pediatrneurol.2021.06.012.


Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in -Suppressed Brain.

Cox R, de Anda F, Mangoubi T, Yoshii A Front Mol Neurosci. 2018; 11:409.

PMID: 30467464 PMC: 6237075. DOI: 10.3389/fnmol.2018.00409.